✦ LIBER ✦

Analysis of risk factors for the development of thrombotic complications in antiphospholipid antibody positive lupus patients

✍ Scribed by Tarr, T; Lakos, G; Bhattoa, H P; Shoenfeld, Y; Szegedi, G; Kiss, E

Book ID: 121713577
Publisher: SAGE Publications
Year: 2007
Tongue: English
Weight: 217 KB
Volume: 16
Category: Article
ISSN: 0961-2033
DOI: 10.1177/0961203306074767

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Reduction of factor XII in antiphospholi

Reduction of factor XII in antiphospholipid antibody-positive patients with thrombotic events in the rheumatology clinic

✍ M. Takeishi; A. Mimori; K. Nakajima; T. Mimura; T. Suzuki 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 108 KB

Presence of antiphospholipid antibody is

Presence of antiphospholipid antibody is a risk factor in thrombotic events in patients with antiphospholipid syndrome or relevant diseases

✍ Koji Habe, Hideo Wada, Takeshi Matsumoto… 📂 Article 📅 2013 🏛 Carden Jennings Publishing 🌐 English ⚖ 231 KB

Lupus nephritis and Raynaud’s phenomenon

Lupus nephritis and Raynaud’s phenomenon are significant risk factors for vascular thrombosis in SLE patients with positive antiphospholipid antibodies

✍ Kittiwan Choojitarom; Orawan Verasertniyom; Kitti Totemchokchyakarn; Kanokrat Na 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 125 KB

Do antiphospholipid antibodies increase

Do antiphospholipid antibodies increase the long-term risk of thrombotic complications in young patients with a recent TIA or ischemic stroke?

✍ M. P. J. Van Goor; C. L. Alblas; F. W. G. Leebeek; P. J. Koudstaal; D. W. J. Dip 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 174 KB

Analysis of risk factors predicting thro

Analysis of risk factors predicting thrombotic and/or haemorrhagic complications in 306 patients with Essential Thrombocythemia

✍ Franca Radaelli; Mariangela Colombi; Rossella Calori; Vittorio Ruggero Zilioli; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB 👁 1 views

## Abstract Thrombotic and haemorrhagic complications are the main causes of morbidity in Essential Thrombocythemia (ET). We investigated the clinical and laboratory characteristics associated with the occurrence of these events with the aim of identifying subgroups of patients who might benefit fr

FACTOR V LEIDEN INCREASES THE RISK OF TH

FACTOR V LEIDEN INCREASES THE RISK OF THROMBOSIS IN PATIENTS WITH ANTIPHOSPHOLIPID ANTIBODIES

✍ Ronit Simantov; Siu K Lo; Jane E Salmon; Lisa R Sammaritano; Roy L Silverstein 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 265 KB